Fahr's Disease (FD) is a rare neurodegenerative disorder of uncertain etiology characterized by abnormal intracranial calcium deposition in the basal ganglia. It initially presents in the 4 th to 6 th decade of life with diverse neuropsychiatric manifestations. The correlation between vascular calcifi cation and coronary artery disease had been studied extensively, but its correlation with cerebrovascular disease remains elusive. Vascular calcifi cation is thus an important risk factor for coronary artery disease. It was also postulated that a similar risk for cerebrovascular disease may be attributable to intracranial vascular calcifi cation. We present the case of a 46-year-old male with progressive affective and cognitive disturbances, parkinsonism and ataxia. Eight years after initial presentation, he developed an acute ischemic infarct in the background of diffuse intracranial calcifi cation characteristic of FD, confi rmed by neuroimaging (Figure 1) . While a number of cases FD with associated stroke or stroke-like symptoms have been reported, we are unaware of such occurrence in a Filipino. A pathologic model linking intracranial vascular calcifi cation in FD with cerebrovascular disease and ischemic stroke has been proposed, and warrants further investigation.
INTRODUCTION
Fahr's disease (FD) is a rare neurodegenerative disorder of uncertain etiology characterized by abnormal, symmetrical intracranial calcium deposition with associated cell loss mostly involving the Basal Ganglia, occurring in the absence of secondary causes of calcifi cation (1) (2) . FD also often involves the Thalamus, Hippocampus, Cerebral Cortex, cerebellar subcortical white matter and dentate nucleus ( Figure 1 )(2). Although its exact incidence is not known, it has an estimated prevalence of <1/1,000,000 (2) . Most cases present with neuropsychiatric symptoms including behavioral changes, progressive cognitive decline, parkinsonism, and cerebellar dysfunction (mainly ataxia) (2) . Although the mechanism of abnormal calcifi cation in FD is unclear, it is commonly postulated to be caused by metastatic calcifi c deposition due to a defect in the blood-brain barrier, or by abnormal calcium and phosphorus metabolism in the brain (1) . Although FD can manifest as either a familial or sporadic disorder, recent genetic studies have identifi ed an abnormal locus in chromosome 14q as responsible for the autosomal dominant form, the most common mode of inheritance (3) . Many different nomenclatures were used in different literatures for the same condition and was criticized for including heterogeneous causes but "Fahr's Disease" is still the most commonly preferred term for this clinical entity (4) .
Hereunder, we present an unusual case of FD in a Filipino, who initially presented with psychiatric symptoms and parkinsonism, and then an acute ischemic stroke (Figure 1 ).
CASE PRESENTATION
A 46-year-old male Filipino with Type II Diabetes Mellitus (controlled with gliclazide 30mg/tab 1 tablet once a day) and no previous neurologic or psychiatric disorder presented in 2008 with progressive social withdrawal, depressed mood, disinhibition, insomnia, and anhedonia. There was no noted family history of cognitive impairment, neurodegenerative diseases, or psychiatric disorders. In particular, FD and/or intracranial calcifi cations were not noted in a 3-generation family tree. He was initially treated as a case of Major Depressive Disorder, with only modest clinical response. Later on, he developed progressive cognitive decline associated with bizarre delusions, language diffi culties, akathisia, bradykinesia, rigidity, stereotypic movements, and ataxia. A plain cranial CT scan done in 2010 revealed heavy, symmetric calcifi cations involving both lentiform nuclei, thalamic pulvinars, both corona radiata and both cerebellar hemispheres. Initial laboratory workups (including serum calcium and phosphorus, and thyroid hormone and parathyroid hormone screens) were not yielding. Thus a clinical diagnosis of FD was made. Various trials with anti-depressants, atypical antipsychotics and anti-parkinsonian drugs were initiated, with modest responses. In the interim, he became incapable of performing his job, and eventually needed assistance in performing his activities of daily living.
On March 1, 2016, he developed sudden onset right-sided weakness, non-rotatory dizziness, and a tendency to fall to the right during ambulation. He was initially seen at the emergency room 5 hours post-ictus with the following vital signs: blood pressure of 130/80 mmHg, cardiac rate of 66 beats/ min, respiratory rate of 20 breaths/min, and temperature of 36.0 C. The general physical examination was unremarkable. No cardiac arrhythmia, heart murmur or carotid bruit was observed. Neurologic examination revealed delayed but appropriate responses, he was able to follow simple commands, right central facial palsy, right hemiparesis (MMT of 3/5), rigidity and bradykinesia, terminal dystaxia with a right Babinski sign.
A cranial MRI revealed an area of restricted diffusion in the left capsuloganglionic region extending to the left corona radiata, consistent with an acute ischemic infarct. The previously noted intracranial calcifi cations were also seen as blooming dark signals in the GRE sequence (Figure 2 ). Magnetic Resonance Angiography (MRA) showed mild atherosclerotic changes of the intracranial arteries. No signifi cant fi ndings were noted on electrocardiography and 2D-echocardiography. Carotid duplex scan showed bilateral atherosclerotic carotid artery disease, (less than 50% Internal carotid artery stenosis with Type V (calcifi ed plaque morphology). Laboratory tests including complete blood count, serum lipid profi le, urinalysis, hepatic and renal function tests were all unremarkable. HbA1C (6.32%) revealed adequate glycemic control, and serum electrolytes including total calcium (2.3 mmol/L) and ionized calcium (1.3 mmol/L) were also within normal limits. He was managed as a case of an acute cerebral infarction. We provided adequate hydration, and our patient was started on clopidogrel (75 mg/day) and atorvastatin (40 mg/day). Anti-psychotic treatment with aripiprazole (10 mg/day) was continued. No progression of neurologic defi cits was observed during his hospital stay, and he was discharged stable.
In a 3 out-patient follow ups, he had a mild residual right hemiparesis (3/5 MMT), yet Parkinsonian and behavioral manifestations prior to the stroke persisted.
DISCUSSION
FD is a rare neurodegenerative disease caused by diffuse intracranial calcium deposition, and presents with a wide range of neuropsychiatric symptoms including behavioral and affective disturbances, progressive cognitive decline, extrapyramidal symptoms and movement disorders, and cerebellar dysfunction. Cases with stroke-like symptoms and seizure as the initial manifestation of the disease have been reported in a few cases (5)(1) (6) . Although it has been postulated that the pathological process of calcium deposition may start as early as 3 decades before the onset of any symptoms, the initial manifestations typically appear during the 4 th to 6 th decade of life, as was the case in our patient whose fi rst symptoms manifested at the age of 46 years (7) . At the molecular level, calcium deposition in FD develops in the walls of capillaries, arterioles, small veins, and in the perivascular space, ultimately extending to the neuron (2). This vascular calcifi cation causes impaired iron transport and free radical production, ultimately leading to neuronal damage with subsequent neuronal calcifi cation. These calcifi cations compress the lumen of surrounding vessels, impeding blood fl ow and further propagating the cycle of neuronal damage and neuronal calcifi cation (1) .
We have presented a case of a 54-year-old male who developed an acute ischemic infarct in the background of diffuse intracranial calcifi cation. Whether in fact the vascular disease of this present case is considered signifi cant (note diabetes mellitus -adequate control [ HgbA1c -6.2 %], unremarkable electrocardiography, less than 50% internal carotid artery stenosis with Type V plaque and unremarkable lipid work-up), the independent association of cerebrovascular disease with FD may remain tenable here. Although some cases were reported regarding such occurrence, we are still unaware of such in a Filipino patient. The impact of such an association warrants further investigation.
